Retinal Biologics Market Key Highlights and Future Opportunities Till 2035
The global retinal biologics market is currently valued at approximately USD 25.65 billion and is projected to reach USD 57.47 billion by 2035, representing a CAGR of 7.61%. Macular degeneration currently accounts for the largest disease-indication segment, while diabetic retinopathy is expected to provide significant future growth opportunities.
For more details on the market, please visit the following URL: https://www.rootsanalysis.com/....reports/retinal-biol
Мне нравится
Комментарий
Поделиться
